31,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

After her diagnosis of triple negative breast cancer (TNBC), health journalist Patricia Prijatel did what any reporter would do: start investigating the disease, how it occurs, and how it's treated. While she learned that important research was emerging, she found a noticeable lack of resources on the disease, which affects 70,000 women a year and differs from hormone-positive breast cancer in important ways, including prognosis and treatment options. InSurviving-Triple Negative Breast Cancer, Prijatel delivers research-based information on the biology of TNBC; the role of genetics, family…mehr

Produktbeschreibung
After her diagnosis of triple negative breast cancer (TNBC), health journalist Patricia Prijatel did what any reporter would do: start investigating the disease, how it occurs, and how it's treated. While she learned that important research was emerging, she found a noticeable lack of resources on the disease, which affects 70,000 women a year and differs from hormone-positive breast cancer in important ways, including prognosis and treatment options. InSurviving-Triple Negative Breast Cancer, Prijatel delivers research-based information on the biology of TNBC; the role of genetics, family history, and race; how to navigate treatment options; and a plethora of strategies to reduce the risk of recurrence. Woven throughout the book are stories of women who havefaced TNBC: mothers, wives, daughters, and sisters who went through a variety of medical treatments and then got on with life.
Autorenporträt
Patricia Prijatel, E.T. Meredith Distinguished Professor Emerita at Drake University, has helped educate, motivate, support, and challenge people for the better part of three decades. She is a nationally published magazine writer, an award-winning teacher, and a well-respected writing coach. Her "Positives About Negative" blog has reached more than 100,000 readers and is one of the few sites that deals specifically with triple negative breast cancer.